COVID-19 Patients with Respiratory Failure to Be Given NuvOx Pharma's Oxygen Therapeutic in Phase IIa Clinical Trial
Jarrod Mosier, MD, associate professor, UArizona Emergency Medicine and Internal Medicine and associate program director of the Critical Care Fellowship at Banner University Medical Center - Tucson, is a principal investigator of the U.S. sites in a Phase IIa clinical trial of NanO2 in COVID-19 subjects with acute hypoxic respiratory failure (AHRF).
Sections:
